Haemonetics Corporation (HAE) Q2 2023 Earnings Results

Haemonetics Corp Misses on EPS, Stock Up 3.61%

Haemonetics Corp's earnings report showed a slight miss on EPS, which may raise concerns among investors. However, the stock reacted positively, increasing by 3.61%. This uptick suggests that investors are optimistic about the company's long-term strategies despite the earnings miss.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.64	N/A	-7.91%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management acknowledged the current challenges impacting earnings but remains focused on long-term growth strategies. They emphasized operational improvements as a key area of focus.

Management highlighted ongoing challenges but expressed confidence in long-term growth.

They noted improvements in operational efficiency as a positive sign.

The focus remains on strategic initiatives to enhance market position.

Haemonetics Corp Misses on EPS, Stock Up 3.61%

Key numbers

Management commentary

Haemonetics Corporation

More earnings this week

Haemonetics Corp Misses on EPS, Stock Up 3.61%

Key numbers

Management commentary